Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H14N4O2 |
| Molecular Weight | 198.2224 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2[C@H](N(C)C(=O)N2C)N(C)C1=O
InChI
InChIKey=XIUUSFJTJXFNGH-OLQVQODUSA-N
InChI=1S/C8H14N4O2/c1-9-5-6(11(3)7(9)13)12(4)8(14)10(5)2/h5-6H,1-4H3/t5-,6+
| Molecular Formula | C8H14N4O2 |
| Molecular Weight | 198.2224 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.rlsnet.ru/tn_index_id_14402.htmCurator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/598490 | https://www.ncbi.nlm.nih.gov/pubmed/3979535
Sources: https://www.rlsnet.ru/tn_index_id_14402.htm
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/598490 | https://www.ncbi.nlm.nih.gov/pubmed/3979535
Tetramethylglycoluril (MEBICAR, Adaptol, Mebicarum) is an anxiolytic similar to organism natural metabolites with nootropic and stress-protective characteristics. Tetramethylglycoluril belongs to a group of non-benzodizepam tranquilizers. It works by effecting on the structure of limbic-reticular activity and 4 main neuromediator systems – γ aminobutyric acid, choline -, serotonin- and adrenergic. Tetramethylglycoluril increases serotonin levels, decreases noradrenaline level with no effect on dopamine and no anticholinergic activity. It acts on hypothalamus emotional zone, thus providing moderate tranquilizing effect. Tetramethylglycoluril improves oxygen consumption by myocardium, normalizes blood electrolyte balance, stimulates protein synthesis and increases cell's energy resource. Tetramethylglycoluril is used to treat neurotic disorders (anxiety, awareness, fear, emotional density, irritability) caused by exhausting psycho-emotional, nervous and physical loads. Mebicar relieves or completely removes nicotine abstinence.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7075749 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.rlsnet.ru/tn_index_id_14402.htm |
Primary | Adaptol Approved UseUnknown |
||
| Primary | Adaptol Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rlsnet.ru/tn_index_id_14402.htm
500 mg 2-3 times a day. The maximum single dose is 3 g, the daily - 10 g. The duration of the course of treatment is from several days to 2-3 months.
In complex therapy as a means of reducing the craving for tobacco smoking - 500-1000 mg 3 times a day for 5-6 weeks.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:54:05 GMT 2025
by
admin
on
Mon Mar 31 19:54:05 GMT 2025
|
| Record UNII |
55FE6NPG89
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QN06BX21
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
||
|
WHO-ATC |
N06BX21
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3707390
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
122282
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
11515
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | INN | ||
|
106780-29-4
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
ALTERNATIVE | |||
|
DTXSID60143588
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
SUB31717
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
55FE6NPG89
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
DB13522
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
10095-06-4
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
100000124183
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
ADAPTOL
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
C015979
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
4861
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY | |||
|
C179125
Created by
admin on Mon Mar 31 19:54:05 GMT 2025 , Edited by admin on Mon Mar 31 19:54:05 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |